NEPH - Nephros sees Q4 revenue in-line with estimates

Nephros (NEPH) sees Q4 revenues of ~$2.3M vs. a consensus of $2.32M.The company ended the year with ~$8.3M in cash on a consolidated basis.Andy Astor, President and CEO: “As the world has begun to adapt to the pandemic, however, our revenues have consistently improved, with sequential quarter-over-quarter gains in both Q3 and Q4. We are optimistic that this trend will continue as we enter 2021, and that our return to high growth rates will be associated with broad vaccine distribution in the coming months.”Press Release

For further details see:

Nephros sees Q4 revenue in-line with estimates,